{"id":12371,"date":"2019-09-18T15:56:01","date_gmt":"2019-09-18T13:56:01","guid":{"rendered":"https:\/\/www.mannheimerswartling.se\/?p=12371"},"modified":"2021-03-10T16:58:10","modified_gmt":"2021-03-10T15:58:10","slug":"cellavision-to-acquire-ral-diagnostics","status":"publish","type":"post","link":"https:\/\/www.mannheimerswartling.se\/en\/assignment\/cellavision-to-acquire-ral-diagnostics\/","title":{"rendered":"CellaVision to acquire RAL Diagnostics"},"content":{"rendered":"<p class=\"preamble\">CellaVision AB (publ) has signed an agreement to acquire the French company RAL Diagnostics (RAL).<\/p>\n<p>RAL manufactures sample preparation products in hematology, pathology, cytology and microbiology. The company&#8217;s reagents help to identify cell and tissue morphology, parasites and bacteria that are necessary to diagnose many illnesses.<\/p>\n<p>CellaVision is an innovative, global medical technology company that develops and sells leading systems for routine analysis of blood and other body fluids in health care services. CellaVision&#8217;s head office is located in Lund and the company has a direct presence in more than 30 countries. CellaVision&#8217;s share is listed on Nasdaq, Stockholm.<\/p>\n<p>CellaVision was advised by Mannheimer Swartling in the transaction.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>CellaVision AB (publ) has signed an agreement to acquire the French company RAL Diagnostics (RAL). RAL manufactures sample preparation products in hematology, pathology, cytology and\u2026<\/p>\n","protected":false},"author":9,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[4313],"tags":[],"class_list":["post-12371","post","type-post","status-publish","format-standard","hentry","category-assignment","business-group-mergers-and-acquisitions"],"acf":[],"lang":"en","translations":{"en":12371,"sv":12367},"pll_sync_post":[],"_links":{"self":[{"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/posts\/12371"}],"collection":[{"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/comments?post=12371"}],"version-history":[{"count":2,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/posts\/12371\/revisions"}],"predecessor-version":[{"id":14330,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/posts\/12371\/revisions\/14330"}],"wp:attachment":[{"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/media?parent=12371"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/categories?post=12371"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/tags?post=12371"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}